Skip to main content

Articles

Page 58 of 65

  1. In addition to its essential role in ribonucleotide reduction, ribonucleotide reductase (RNR) small subunit, RRM2, has been known to play a critical role in determining tumor malignancy. Overexpression of RRM2...

    Authors: Keqiang Zhang, Shuya Hu, Jun Wu, Linling Chen, Jianming Lu, Xiaochen Wang, Xiyong Liu, Bingsen Zhou and Yun Yen
    Citation: Molecular Cancer 2009 8:11
  2. In eukaryotic cells, control mechanisms have developed that restrain cell-cycle transitions in response to stress. These regulatory pathways are termed cell-cycle checkpoints. The G2/M checkpoint prevents cells f...

    Authors: Yingmei Wang, Ping Ji, Jinsong Liu, Russell R Broaddus, Fengxia Xue and Wei Zhang
    Citation: Molecular Cancer 2009 8:8
  3. We recently have shown that Charged multivesicular protein/Chromatin modifying protein1A (Chmp1A) functions as a tumor suppressor in human pancreatic tumor cells. Pancreatic cancer has the worst prognosis of a...

    Authors: Jing Li, Brandon Orr, Kayla White, Natalia Belogortseva, Richard Niles, Goran Boskovic, Hanh Nguyen, Ava Dykes and Maiyon Park
    Citation: Molecular Cancer 2009 8:7
  4. Brain and nervous system tumours are the most common solid cancers in children. Molecular characterisation of these tumours is important for providing novel biomarkers of disease and identifying molecular path...

    Authors: Martin Wilson, Nigel P Davies, Marie-Anne Brundler, Carmel McConville, Richard G Grundy and Andrew C Peet
    Citation: Molecular Cancer 2009 8:6
  5. The ability to detect neoplasia-specific fusion genes is important not only in cancer research, but also increasingly in clinical settings to ensure that correct diagnosis is made and the optimal treatment is ...

    Authors: Rolf I Skotheim, Gard OS Thomassen, Marthe Eken, Guro E Lind, Francesca Micci, Franclim R Ribeiro, Nuno Cerveira, Manuel R Teixeira, Sverre Heim, Torbjørn Rognes and Ragnhild A Lothe
    Citation: Molecular Cancer 2009 8:5
  6. CDKN2A/p16 INK4a is frequently altered in human cancers and it is the most important melanoma susceptibility gene identified to date. p16INK4a inhibits pRb phosphorylation an...

    Authors: Therese M Becker, Sebastian Haferkamp, Menno K Dijkstra, Lyndee L Scurr, Monika Frausto, Eve Diefenbach, Richard A Scolyer, David N Reisman, Graham J Mann, Richard F Kefford and Helen Rizos
    Citation: Molecular Cancer 2009 8:4
  7. Cellular immortalization is a crucial step during the development of human cancer. Primary mammalian cells reach replicative exhaustion after several passages in vitro, a process called replicative senescence. Du...

    Authors: Matilde E LLeonart, Ana Artero-Castro and Hiroshi Kondoh
    Citation: Molecular Cancer 2009 8:3
  8. Bioluminescent imaging (BLI) is based on the detection of light emitted by living cells expressing a luciferase gene. Stable transfection of luciferase in cancer cells and their inoculation into permissive ani...

    Authors: Maider Zabala, Pilar Alzuguren, Carolina Benavides, Julien Crettaz, Gloria Gonzalez-Aseguinolaza, Carlos Ortiz de Solorzano, Manuela Gonzalez-Aparicio, Maria Gabriela Kramer, Jesus Prieto and Ruben Hernandez-Alcoceba
    Citation: Molecular Cancer 2009 8:2
  9. Homeodomain-interacting protein kinase-2 (HIPK2), a transcriptional co-repressor with apoptotic function, can affect hypoxia-inducible factor 1 (HIF-1) transcriptional activity, through downmodulation of its H...

    Authors: Lavinia Nardinocchi, Rosa Puca, Ada Sacchi and Gabriella D'Orazi
    Citation: Molecular Cancer 2009 8:1
  10. Multiple epigenetic and genetic changes have been reported in colorectal tumors, but few of these have clinical impact. This study aims to pinpoint epigenetic markers that can discriminate between non-malignan...

    Authors: Terje Ahlquist, Guro E Lind, Vera L Costa, Gunn I Meling, Morten Vatn, Geir S Hoff, Torleiv O Rognum, Rolf I Skotheim, Espen Thiis-Evensen and Ragnhild A Lothe
    Citation: Molecular Cancer 2008 7:94
  11. LIM-only 4 (LMO4), a member of the LIM-only (LMO) subfamily of LIM domain-containing transcription factors, was initially reported to have an oncogenic role in breast cancer. We hypothesized that LMO4 may be r...

    Authors: Jun Yu, Kenoki Ohuchida, Kohei Nakata, Kazuhiro Mizumoto, Lin Cui, Hayato Fujita, Hiroshi Yamaguchi, Takuya Egami, Hidehisa Kitada and Masao Tanaka
    Citation: Molecular Cancer 2008 7:93
  12. KRAS and BRAF mutations appear of relevance in the genesis and progression of several solid tumor types but the co-occurrence and interaction of these mutations have not yet been fully elucidated. Using a microsa...

    Authors: Massimiliano Monticone, Emanuela Biollo, Massimo Maffei, Alessandra Donadini, Francesco Romeo, Clelia Tiziana Storlazzi, Walter Giaretti and Patrizio Castagnola
    Citation: Molecular Cancer 2008 7:92
  13. Overexpression of HER-2/Neu occurs in about 25–30% of breast cancer patients and is indicative of poor prognosis. While Her2/Neu overexpression is primarily a result of erbB2 amplification, it has recently bee...

    Authors: Prudence B Lam, Laura N Burga, Bryan P Wu, Erin W Hofstatter, Kun Ping Lu and Gerburg M Wulf
    Citation: Molecular Cancer 2008 7:91
  14. Peroxisome proliferator-activated receptor gamma (PPARγ) is a member of the nuclear hormone receptor superfamily and is highly expressed in many human tumors including breast cancer. PPARγ has been identified ...

    Authors: Yekaterina Y Zaytseva, Xin Wang, R Chase Southard, Natalie K Wallis and Michael W Kilgore
    Citation: Molecular Cancer 2008 7:90
  15. Papillary thyroid carcinoma (PTC) frequently presents as multiple tumour-foci within a single thyroid gland or pluriform, with synchronous tumours comprising different histological variants, raising questions ...

    Authors: Sinéad T Aherne, Paul C Smyth, Richard J Flavin, Susan M Russell, Karen M Denning, Jing Huan Li, Simone M Guenther, John J O'Leary and Orla M Sheils
    Citation: Molecular Cancer 2008 7:89
  16. Recently we have reported membrane androgen receptors-induced apoptotic regression of prostate cancer cells regulated by Rho/ROCK/actin signaling. In the present study we explored the specificity of these rece...

    Authors: Natalia Papadopoulou, Ioannis Charalampopoulos, Vasileia Anagnostopoulou, Georgios Konstantinidis, Michael Föller, Achilleas Gravanis, Konstantinos Alevizopoulos, Florian Lang and Christos Stournaras
    Citation: Molecular Cancer 2008 7:88
  17. Aldehyde dehydrogenase isozymes ALDH1A1 and ALDH3A1 are highly expressed in non small cell lung cancer. Neither the mechanisms nor the biologic significance for such over expression have been studied.

    Authors: Jan S Moreb, Henry V Baker, Lung-Ji Chang, Maria Amaya, M Cecilia Lopez, Blanca Ostmark and Wayne Chou
    Citation: Molecular Cancer 2008 7:87
  18. Convictions are a driving force for actions. Considering that every individual has a different set of convictions and larger groups act once a consensus decision is reached, one can see that debate is an inher...

    Authors: Hassan R Naqvi, Shawn Mathur, David Covarrubias, Josephine A Curcio and Christian Schmidt
    Citation: Molecular Cancer 2008 7:86
  19. Tissue inhibitors of metalloproteinases (TIMPs) regulate diverse processes, including extracellular matrix (ECM) remodeling, and growth factors and their receptors' activities through the inhibition of matrix ...

    Authors: Jorge Melendez-Zajgla, Luis Del Pozo, Gisela Ceballos and Vilma Maldonado
    Citation: Molecular Cancer 2008 7:85
  20. Younger women with breast carcinoma (BC) exhibits more aggressive pathologic features compared to older women; young age could be an independent predictor of adverse prognosis. To find any existing differences...

    Authors: Satyabrata Sinha, Ratnesh K Singh, Neyaz Alam, Anup Roy, Susanta Roychoudhury and Chinmay Kumar Panda
    Citation: Molecular Cancer 2008 7:84
  21. We have previously reported that expression of the Wnt antagonist genes SFRP1 and SFRP5 is frequently silenced by promoter hypermethylation in breast cancer. SFRP2 is a further Wnt inhibitor whose expression was ...

    Authors: Jürgen Veeck, Erik Noetzel, Nuran Bektas, Edgar Jost, Arndt Hartmann, Ruth Knüchel and Edgar Dahl
    Citation: Molecular Cancer 2008 7:83
  22. Cancer rates are set to increase at an alarming rate, from 10 million new cases globally in 2000 to 15 million in 2020. Regarding the pharmacological treatment of cancer, we currently are in the interphase of ...

    Authors: Alfonso Dueñas-González, Patricia García-López, Luis Alonso Herrera, Jose Luis Medina-Franco, Aurora González-Fierro and Myrna Candelaria
    Citation: Molecular Cancer 2008 7:82
  23. Chromosomal translocations play a crucial role in tumorigenesis, often resulting in the formation of chimeric genes or in gene deregulation through position effects. T-cell acute lymphoblastic leukemia (T-ALL)...

    Authors: Maria Corsignano Guastadisegni, Angelo Lonoce, Luciana Impera, Francesco Albano, Pietro D'Addabbo, Sebastiano Caruso, Isabella Vasta, Ioannis Panagopoulos, Anna Leszl, Giuseppe Basso, Mariano Rocchi and Clelia Tiziana Storlazzi
    Citation: Molecular Cancer 2008 7:80
  24. The functional status of a cell is expressed in its metabolic activity. We have applied stable isotope tracing methods to determine the differences in metabolic pathways in proliferating Rhabdomysarcoma cells ...

    Authors: Teresa WM Fan, Magda Kucia, Kacper Jankowski, Richard M Higashi, Janina Ratajczak, Marius Z Ratajczak and Andrew N Lane
    Citation: Molecular Cancer 2008 7:79
  25. Constitutive activation of signal transducer and activator of transcription 3 (Stat3) signaling pathway plays an important role in several human cancers. Activation of Stat3 is dependent on the phosphorylation...

    Authors: Chun-Liang Chen, Ling Cen, Jennifer Kohout, Brian Hutzen, Christina Chan, Fu-Chuan Hsieh, Abbey Loy, Victor Huang, Gong Cheng and Jiayuh Lin
    Citation: Molecular Cancer 2008 7:78
  26. The c-Myb protein is a transcriptional regulator initially identified by homology to the v-Myb oncoprotein, and has since been implicated in human cancer. The most highly conserved portion of the c-Myb protein...

    Authors: Emily Ray Ko, Dennis Ko, Carolyn Chen and Joseph S Lipsick
    Citation: Molecular Cancer 2008 7:77
  27. The use of human embryonic stem cells (hESCs) in research is increasing and hESCs hold the promise for many biological, clinical and toxicological studies. Human ESCs are expected to be chromosomally stable si...

    Authors: Puri Catalina, Rosa Montes, Gertru Ligero, Laura Sanchez, Teresa de la Cueva, Clara Bueno, Paola E Leone and Pablo Menendez
    Citation: Molecular Cancer 2008 7:76
  28. Barrett's esophagus (BE) is the metaplastic replacement of squamous with columnar epithelium in the esophagus, as a result of reflux. It is the major risk factor for the development of esophageal adenocarcinom...

    Authors: Eric Smith, Neville J De Young, Sandra J Pavey, Nicholas K Hayward, Derek J Nancarrow, David C Whiteman, B Mark Smithers, Andrew R Ruszkiewicz, Andrew D Clouston, David C Gotley, Peter G Devitt, Glyn G Jamieson and Paul A Drew
    Citation: Molecular Cancer 2008 7:75
  29. MicroRNA (miRNA) dysregulation frequently occurs in cancer. Analysis of whole blood miRNA in tumor models has not been widely reported, but could potentially lead to novel assays for early detection and monito...

    Authors: Alice C Fan, Marianna M Goldrick, Jennifer Ho, Yu Liang, Pavan Bachireddy and Dean W Felsher
    Citation: Molecular Cancer 2008 7:74
  30. β-catenin is a key mediator of the canonical Wnt pathway as it associates with members of the T-cell factor (TCF) family at Wnt-responsive promoters to drive the transcription of Wnt target genes. Recently, we...

    Authors: Pinella Buongiorno, Vaijayanti V Pethe, George S Charames, Susmita Esufali and Bharati Bapat
    Citation: Molecular Cancer 2008 7:73
  31. Apart from genetic alterations, development and progression of colorectal cancer has been linked to influences from nutritional intake, hyperalimentation, and cellular metabolic changes that may be the basis f...

    Authors: Carsten Denkert, Jan Budczies, Wilko Weichert, Gert Wohlgemuth, Martin Scholz, Tobias Kind, Silvia Niesporek, Aurelia Noske, Anna Buckendahl, Manfred Dietel and Oliver Fiehn
    Citation: Molecular Cancer 2008 7:72
  32. To investigate the expression of EPLIN-α, epithelial protein lost in neoplasm, in human breast cancer tissues/cells and investigate the cellular impact of EPLIN-α on breast cancer cells.

    Authors: Wen G Jiang, Tracey A Martin, Jonathan M Lewis-Russell, Anthony Douglas-Jones, Lin Ye and Robert E Mansel
    Citation: Molecular Cancer 2008 7:71
  33. Histone acetylation is an epigenetic modification involved in the regulation of gene expression, balanced by histone acetyl transferases and histone deacetylase (HDAC) enzymes. HDAC inhibitors (HDACi) induce g...

    Authors: Marielle Dejligbjerg, Morten Grauslund, Thomas Litman, Laura Collins, Xiaozhong Qian, Michael Jeffers, Henri Lichenstein, Peter Buhl Jensen and Maxwell Sehested
    Citation: Molecular Cancer 2008 7:70
  34. We have identified an alternative pathway of tumorigenesis in sporadic colon cancer, involving microsatellite instability due to mismatched repair methylation, which may be driven by mutations in the BRAF gene...

    Authors: Hassan Brim, Pooneh Mokarram, Fakhraddin Naghibalhossaini, Mehdi Saberi-Firoozi, Mansour Al-Mandhari, Kamla Al-Mawaly, Rayhaneh Al-Mjeni, Abeer Al-Sayegh, Sandy Raeburn, Edward Lee, Francis Giardiello, Duane T Smoot, Alexander Vilkin, C Richard Boland, Ajay Goel, Mitra Hafezi…
    Citation: Molecular Cancer 2008 7:68
  35. Childhood pre-B acute lymphoblastic leukemia (ALL) is a bone marrow (BM) derived disease, which often disseminates out of the BM cavity, where malignant cells to a variable degree can be found circulating in t...

    Authors: Frida Hansson, Jacek Toporski, Robert Månsson, Bertil Johansson, Ulrika Norén-Nyström, Sten Eirik W Jacobsen, Thomas Wiebe, Marcus Larsson, Mikael Sigvardsson and Anders Castor
    Citation: Molecular Cancer 2008 7:67
  36. The clinical efficacy of camptothecin (CPT), a drug specifically targeting topoisomerase I (TopoI), is under evaluation for the treatment of malignant gliomas. Due to the high unresponsiveness of these tumours...

    Authors: Elena Morandi, Cinzia Severini, Daniele Quercioli, Giovanni D'Ario, Stefania Perdichizzi, Miriam Capri, Giovanna Farruggia, Maria Grazia Mascolo, Wolfango Horn, Monica Vaccari, Roberto Serra, Annamaria Colacci and Paola Silingardi
    Citation: Molecular Cancer 2008 7:66
  37. Pancreatic ductal adenocarcinoma (PDAC) is one of the most common causes of cancer related death. Despite the advances in understanding of the molecular pathogenesis, pancreatic cancer remains a major unsolved...

    Authors: Rainer Hamacher, Roland M Schmid, Dieter Saur and Günter Schneider
    Citation: Molecular Cancer 2008 7:64
  38. By nature, scientists contribute to our understanding of nature and ourselves. As communities undergo significant changes, new challenges are presented. Here, we offer alternative views on recent changes in so...

    Authors: Laura M Christian, Hassan R Naqvi, Christian Schmidt, David Covarrubias and Shawn Mathur
    Citation: Molecular Cancer 2008 7:63
  39. Lung cancer is the leading cause of cancer death in men and women in the United States and Western Europe. Over 160,000 Americans die of this disease every year. The five-year survival rate is 15% – significan...

    Authors: Paul P Anglim, Janice S Galler, Michael N Koss, Jeffrey A Hagen, Sally Turla, Mihaela Campan, Daniel J Weisenberger, Peter W Laird, Kimberly D Siegmund and Ite A Laird-Offringa
    Citation: Molecular Cancer 2008 7:62
  40. Chromatin-associated histone H2AX is a key regulator of the cellular responses to DNA damage. However, non-nucleosomal functions of histone H2AX are poorly characterized. We have recently shown that soluble H2...

    Authors: Ying Liu, Joshua A Parry, Anna Chin, Stefan Duensing and Anette Duensing
    Citation: Molecular Cancer 2008 7:61
  41. Drug resistance is a major concern in cancer therapy. Here, we investigate the clinical potential of the second mitochondria-derived activator of caspase (Smac/DIABLO) in enhancing the apoptosis-inducing poten...

    Authors: Tamer E Fandy, Sharmila Shankar and Rakesh K Srivastava
    Citation: Molecular Cancer 2008 7:60
  42. Authors: Cinzia Di Pietro, Marco Ragusa, Davide Barbagallo, Laura R Duro, Maria R Guglielmino, Alessandra Majorana, Veronica Giunta, Antonella Rapisarda, Elisa Tricarichi, Marco Miceli, Rosario Angelica, Agata Grillo, Barbara Banelli, Isabella Defferari, Stefano Forte, Alessandro Laganà…
    Citation: Molecular Cancer 2008 7:59

    The original article was published in Molecular Cancer 2008 7:52

  43. Copy number gains and amplifications are characteristic feature of cervical cancer (CC) genomes for which the underlying mechanisms are unclear. These changes may possess oncogenic properties by deregulating t...

    Authors: Luigi Scotto, Gopeshwar Narayan, Subhadra V Nandula, Shivakumar Subramaniyam, Andreas M Kaufmann, Jason D Wright, Bhavana Pothuri, Mahesh Mansukhani, Achim Schneider, Hugo Arias-Pulido and Vundavalli V Murty
    Citation: Molecular Cancer 2008 7:58
  44. Certain endogenous metabolites can influence the rate of cancer cell growth. For example, diacylglycerol, ceramides and sphingosine, NAD+ and arginine exert this effect by acting as signaling molecules, while car...

    Authors: Adrian K Arakaki, Roman Mezencev, Nathan J Bowen, Ying Huang, John F McDonald and Jeffrey Skolnick
    Citation: Molecular Cancer 2008 7:57
  45. Photodynamic therapy (PDT) involves the administration of a tumor-localizing photosensitizing drug, which is activated by light of specific wavelength in the presence of molecular oxygen thus generating reacti...

    Authors: Ramaswamy Bhuvaneswari, Yik Y Gan, Sasidharan S Lucky, William WL Chin, Seyed M Ali, Khee C Soo and Malini Olivo
    Citation: Molecular Cancer 2008 7:56

Annual Journal Metrics

  • 2022 Citation Impact
    37.3 - 2-year Impact Factor
    33.1 - 5-year Impact Factor
    5.740 - SNIP (Source Normalized Impact per Paper)
    8.703 - SJR (SCImago Journal Rank)

    2023 Speed
    5 days submission to first editorial decision for all manuscripts (Median)
    91 days submission to accept (Median)

    2023 Usage 
    3,569,666 downloads
    2,070 Altmetric mentions